Clinical Trials for Interleukin (IL-2, Aldesleukin)

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
CorrelativeVICCMEL1081
09/28/2011
The High-Dose Aldesleukin (IL-2) "Select" Trial: A Prospective Tissue Collection Protocol to Investigate Predictive Models of Response to High Dose IL-2 Treatment in Patients with Advanced Melanoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.